We consider problems of choice of sample size and allocation in the clinical trials context when utilities are explicitly taken into account. In particular, we consider utilities of benefits and side-effects (and their trade-offs), as well as utility functions that trade-off scientific and ethical concerns.
No takes yet. Share an insight, caveat, or question.
Tan et al. (1998) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: